In addition to diagnosis and localization, PSMA-PET can also be used for prognostic testing of prostate hyperplasia, with poor detection effect at low PSA levels, while 18F-PSMA-1007 performs better in some cases. Here, FOLH1 is linked to benign prostatic hyperplasia.